GL1X · GenesisL1 explorer

Research workbench

Crystal structure resolution of plasmodium falciparum FK506 binding domain (FKBP35) in complex with rapamycin at 1.4A resolution

Analyse Crystal structure resolution of plasmodium falciparum FK506 binding domain… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4QT3
Type
protein
Length
125 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
FK506-binding protein (fkbp)-type peptidyl-propyl isomerase
EC
5.2.1.8
UniProt
Q8I4V8
Ligands
DTV, RAP
Pockets
1 · best druggability 0.37

Structure

x-ray diffraction · 1 distinct chain · 10% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AFK506-binding protein (fkbp)-type peptidyl-propyl isomerase (EC 5.2.1.8)protein12510% helix, 38% strandQ8I4V8

Ligands and binding sites

  • DTV · (2S,3S)-1,4-dimercaptobutane-2,3-diol · ligand · chains A
  • RAP · Rapamycin immunosuppressant drug · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1630.370.7714empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 4QT3 · Crystal structure resolution of Plasmodium falciparum FK506 binding domain (FKBP35) in… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8I4V8 · AlphaFold monomer V2.0 prediction for peptidyl-prolyl cis-trans isomerase FKBP35 (Q8I4V8) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.